Related Experiment Video
Updated: Jul 13, 2026
05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
[Thyroidectomy with LigaSure versus traditional thyroidectomy: our experience].
Antonio Marrazzo1, Luigi Casà, Massimo David
1Dipartimento di Oncologia Sperimentale e Applicazioni Cliniche, Università degli Studi di Palermo.
Chirurgia Italiana
|August 1, 2007
Summary
The LigaSure haemostatic system significantly reduces operative times and hospital stays for total thyroidectomy compared to conventional methods. While complication rates were similar, LigaSure offers a more efficient surgical approach for thyroid disease.
Area of Science:
- Surgical Oncology
- Endocrine Surgery
- Minimally Invasive Surgical Techniques
Context:
- Total thyroidectomy is the standard surgical procedure for various thyroid diseases, both benign and malignant.
- Effective hemostasis is crucial for minimizing complications associated with thyroidectomy.
- Advancements in surgical technology aim to improve patient outcomes and procedural efficiency.
Purpose:
- To evaluate the efficacy of the LigaSure haemostatic system in total thyroidectomy.
- To compare operative times, postoperative complications, and hospital stay between LigaSure and conventional hemostasis.
- To determine if LigaSure reduces the incidence of surgical complications in thyroidectomy.
Summary:
- A randomized study compared total thyroidectomy using LigaSure versus conventional hemostasis in 50 patients.
- LigaSure group demonstrated significantly shorter operative times (60 vs. 92.4 min) and hospital stays (1.88 vs. 2.2 days).
- Postoperative complication rates, including hypocalcemia and recurrent laryngeal nerve issues, were comparable between groups.
Impact:
- The LigaSure system offers a more efficient and potentially less time-consuming approach to total thyroidectomy.
- This technology may contribute to reduced healthcare resource utilization due to shorter hospital stays.
- Further research can explore long-term outcomes and cost-effectiveness of LigaSure in endocrine surgery.
